Comorbidity With Substance Abuse P a g e 1

Size: px
Start display at page:

Download "Comorbidity With Substance Abuse P a g e 1"

Transcription

1 Comorbidity With Substance Abuse P a g e 1 Comorbidity With Substance Abuse Introduction This interesting session provided an overview of recent findings in the diagnosis and treatment of several psychiatric disorders that commonly co-occur with substance use disorders. Several epidemiologic survey studies conducted in the past 15 years have demonstrated that many psychiatric disorders and substance use disorders co-occur far more commonly than would be expected by chance alone. In the Epidemiologic Catchment Area Study,[1,2] an estimated 45% of individuals with an alcohol use disorder and 72% of individuals with a drug use disorder had a least one co-occurring psychiatric disorder. In the National Co- Morbidity Study (NCS),[3] probably the best known of the recent survey studies, it was found that approximately 78% of alcohol-dependent men and 86% of alcohol-dependent women met criteria for another psychiatric disorder, including drug dependence and antisocial personality disorder. Interest in the cooccurrence of psychiatric and substance use disorders is clinically important because comorbidity has been found to have a negative impact on the course, treatment outcome, and prognosis of both syndromes. In this symposium, the relationship between substance use disorders and specific anxiety and mood disorders and ADHD was explored. Depression and Substance Use Disorders In the first talk, Dr. Edward Nunes,[4] a Professor of Psychiatry from Columbia University School of Medicine, spoke about the comorbidity of depression and substance use disorders. Dr. Nunes pointed out that depressed mood, dysthymia, and major depressive episode are among the most common symptoms and disorders seen in individuals with substance use disorders. This comorbidity has

2 Comorbidity With Substance Abuse P a g e 2 also been the subject of a great deal of research focused on issues concerning differential diagnosis and pharmacotherapeutic and psychotherapeutic treatment. In spite of this, there are still many unanswered questions. With regard to diagnosis, there is a great deal of symptom overlap between symptoms of depression and withdrawal symptoms from alcohol and many drugs of abuse. This can make differential diagnosis difficult. Studies in treatment-seeking samples have resulted in variable estimates of the comorbidity of affective illness with substance use disorders. Estimates of the prevalence of depressive disorders in treatment-seeking, alcoholic individuals range from 15% to 67%. In studies of cocaine-dependent individuals, estimates of affective comorbidity range from 33% to 53%. Bipolar disorders appear to be more prevalent (20% to 30%) among cocaine-dependent individuals than among alcoholic individuals. In opiate-dependent samples, rates of lifetime affective disorder (primarily depressive disorders) range from 16% to 75%. While there has been a great deal of discussion about distinguishing primary vs secondary depression, depending on the relative order of onset of the disorders, there is not much evidence that the primary/secondary distinction makes a difference in terms of treatment response. There have been a number of studies of both pharmacotherapeutic and psychotherapeutic treatments for individuals with co-occurring depression and substance use disorders. Several studies have indicated that tricyclic antidepressants are efficacious in the treatment of comorbid depression with alcohol-, cocaine-, and opiate-dependent individuals. Unfortunately, in many of these studies, there was improvement in depression, but not in substance use-related outcomes. In some studies, medication was initiated in individuals while they were still actively using substances. The medications improved symptoms of depression even in individuals who were actively using at the time of medication initiation. Dr. Nunes also presented some interesting findings from a research group[5] studying the impact of cognitive behavioral therapy (CBT) in alcohol-dependent individuals with comorbid major depression. In the study, the efficacy of an integrated CBT that was specifically

3 Comorbidity With Substance Abuse P a g e 3 designed for alcoholism and depression was compared with a relaxation training control group. The authors found that those individuals treated with the integrated treatment approach had better outcomes with regard to both alcohol consumption and symptoms of depression at the 3- and 6-month follow-up visits. ADHD and Substance Use Disorders The next speaker was Dr. Tim Wilens,[6] from Harvard University, discussing the comorbidity of attention-deficit/hyperactivity disorder (ADHD) and substance use disorders. Dr. Wilens spoke about the increasing awareness of ADHD in both children and adults and the evidence that ADHD is commonly comorbid with substance use disorders. In some studies, it has been demonstrated that the link between ADHD and substance use disorders is usually through conduct disorder or antisocial personality disorder. Both ADHD and substance use disorders are commonly comorbid with conduct disorders and most often those individuals with ADHD who develop substance use disorders also have a conduct disorder. For those individuals with ADHD who do not have conduct disorder, the comorbidity with substance use disorders is not nearly as striking. Dr. Wilens also addressed the controversial area of the use of stimulant drugs in children with ADHD and in adults with ADHD and comorbid substance use disorders. There has been some speculation that because stimulant drugs used in the treatment of ADHD, such as methylphenidate, have abuse potential, the link between ADHD in children and the development of substance use disorders in adolescents and adults may be causal. In other words, the use of stimulants in children may predispose them to the development of substance use disorders as adults. Dr. Wilens and colleagues recently published a thorough review of the literature[7] in which they concluded that the majority of the literature supports the idea that medication treatment of ADHD in childhood actually has a protective effect with regard to the development of substance use disorders during adolescence or adulthood. They hypothesized that this protective effect may be a result of the fact that treatment of ADHD makes it more likely that a child will be successful in school and other areas, therefore making them less likely to be at risk for the development of a substance use disorder.

4 Comorbidity With Substance Abuse P a g e 4 PTSD and Substance Use Disorders Dr. Kathleen Brady,[8] from the Medical University of South Carolina, spoke next about the co-occurrence of posttraumatic stress disorder (PTSD) and substance use disorders. Victimization, violence, and trauma are often a part of the life history of individuals with substance use disorders. PTSD is one of the most common anxiety disorders in individuals with substance use disorders. In the NCS, the odds ratio for substance use disorders was 2-3 for men and for women with PTSD. In treatment settings for substance use disorders, a number of studies have reported rates of current PTSD between 20% and 45%. Individuals with comorbid PTSD and substance use have a worse course of illness with more hospitalizations, less compliance with aftercare treatment, and poorer functional improvement. For many years, the conventional wisdom in substance abuse treatment settings was to aggressively treat the substance use disorder but not address traumarelated issues until an individual had several months of abstinence. Unfortunately, many individuals suffering with symptoms of PTSD cannot attain sobriety because PTSD symptoms, such as sleep disturbance and intrusive thoughts, can drive continued substance use. Therefore, the development of treatments specifically tailored to address trauma-related issues during early recovery has been a focus of much recent investigation. One of the most widely used manualized psychotherapy, which uses a combination of techniques from both the addiction and PTSD fields, is Seeking Safety, developed by Lisa Najavits from Harvard University.[9] This is a session group or individual therapy that focuses on understanding trauma-related symptoms, healthy behaviors, and relapse prevention. This therapy is under investigation in a multisite trial sponsored by the National Institute on Drug Abuse. Dr. Brady then presented some data from a study conducted by her research group from the Medical University of South Carolina on the efficacy of sertraline

5 Comorbidity With Substance Abuse P a g e 5 in the treatment of co-occurring PTSD and alcohol dependence. Sertraline has demonstrated efficacy in the treatment of PTSD in nonalcohol-dependent individuals. In this study, sertraline had a modest impact on the symptoms of PTSD. When the data from the group were analyzed as a whole, sertraline did not have an impact on alcohol-related outcomes. In a post-hoc analysis, however, the study sample was divided into a group who had early onset PTSD, later onset alcohol abuse, and a group who had early onset alcohol abuse, later onset PTSD. Sertraline was very efficacious in improving alcohol-related outcomes in the early onset PTSD group, but not in the early onset alcohol abuse group. These data suggest that subtyping comorbid populations for the purpose of treatment matching could be important in choosing the most efficacious treatment for a specific patient. Social Phobia and Substance Use Disorder The next speaker was Dr. Hugh Myrick,[10] from the Medical University of South Carolina. Dr. Myrick's presentation focused on the comorbidity of social phobia and substance use disorders. Dr. Myrick began with an overview of the characteristics of social phobia and the substantial functional impairment associated with this disorder. Social anxiety disorder is defined as a marked and persistent fear of situations in which an individual is exposed to unfamiliar people or to the scrutiny of others. Fear of being embarrassed or evaluated negatively is the hallmark of the disorder. This fear often leads to avoidance of feared situations and results in impairment in academic, occupational, and social functioning. In spite of the prevalence and high price of social phobia, it is often unrecognized and/or trivialized as just "shyness." A number of studies have emphasized the high comorbidity of social phobia with a number of other psychiatric disorders, including substance use disorders. Studies of treatment-seeking alcoholics and drug-dependent individuals also indicate a high percentage of individuals meeting criteria for social phobia (approximately 10% to 15%), but the disorder is rarely diagnosed in substance

6 Comorbidity With Substance Abuse P a g e 6 abuse treatment settings. Early recognition of the individual with comorbid social anxiety disorder and substance use is paramount to an improved chance of recovery because the social anxiety disorder may interfere with an individual's ability to engage effectively in treatment. In an interview study of socially phobic, alcohol-dependent individuals, most reported the onset of social phobia was earlier than the onset of drinking. They also reported using alcohol to make themselves more comfortable in social situations, but generally not using alcohol in a work setting or any other settings in which performance would be evaluated. Dr. Carrie Randall and colleagues,[11] also at the Medical University of South Carolina, has conducted both a pharmacotherapy and a psychotherapy study of the treatment of alcoholdependent individuals with social phobia. In the psychotherapy study, they compared a 12-session manualized treatment that combined social phobia CBT with relapse prevention techniques from the alcohol treatment field with CBT relapse prevention for alcohol only. Surprisingly, the group that received the combined treatment actually had poorer outcomes. The investigators speculate that aggressive treatment of social phobia may make it difficult for individuals to concentrate on their sobriety. They suggest that it may be an issue of timing -- perhaps treatment of social phobia following relapse prevention treatment would be a better strategy. This area clearly needs further study. In another pilot study, Dr. Randall and colleagues[12] studied the use of paroxetine in socially phobic alcohol-dependent individuals. They found that the group treated with paroxetine had better outcomes in terms of social phobia and a trend toward better alcohol-related outcomes. The trial was brief (8 weeks), and many of the treatment effects were just beginning to emerge at the end of the trial. They are now conducting a longer and larger double-blind, placebocontrolled trial funded by the National Institutes of Health. The discussion was conducted by Richard Rosenthal, a Professor of Psychiatry at Columbia University School of Medicine and the current president of the

7 Comorbidity With Substance Abuse P a g e 7 American Academy of Addiction Psychiatry. Dr. Rosenthal pointed out some of the common themes of the talks in the symposium. The idea of integrated treatment has been a critical part of treatment of comorbidity. In all of the presentations, new advances in treatment integration, both pharmacotherapeutic and psychotherapeutic, were presented. Dr. Rosenthal also stressed the idea of subtyping substance dependent individuals for the purposes of individualizing treatment. For a long time, substance abuse treatment has followed the "one size fits all" model. Particularly with regard to psychiatric comorbidity, it is clear that this approach does not work. Careful psychiatric diagnosis and appropriate treatment of psychiatric symptoms are critical to maximizing patient outcomes. References 1.essler RC, Nelson CB, McGonagle KA, et al. The epidemiology of co-occurring addictive and mental disorders: implications for prevention and service utilization. Am J Orthopsychiatry. 1996;66: Abstract 2.Eaton WW, Regier DA, Locke BZ, Taube CA. The Epidemiologic Catchment Area Program of the National Institute of Mental Health. Public Health Rep. 1981;96: Abstract 3.Regier DA, Farmer ME, Rae DS, et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA. 1990;264: Abstract 4.Nunes EV. Substance abuse and depression. Program and abstracts of the American Psychiatric Association 156th Annual Meeting; May 17-22, 2003; San Francisco, California. Abstract S103A. 5.Brown RA, Evans DM, Miller IW, et al. Cognitive-behavioral treatment for depression in alcoholism. J Consult Clin Psychol. 1997;65: Abstract 6.Wilens TE. Substance abuse and ADD. Program and abstracts of the American Psychiatric Association 156th Annual Meeting; May 17-22, 2003; San Francisco, California. Abstract S103C.

8 Comorbidity With Substance Abuse P a g e 8 7.Wilens TE, Faraone SV, Biederman J, Gunawardene S. Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A metaanalytic review of the literature. Pediatrics. 2003;111: Abstract 8.Brady KT, Sonne S, Killeen T, McRae A. Substance abuse and PTSD. Program and abstracts of the American Psychiatric Association 156th Annual Meeting; May 17-22, 2003; San Francisco, California. Abstract S103B. 9.Najavits LM, Weiss RD, Liese BS. Group cognitive-behavioral therapy for women with PTSD and substance use disorder. J Subst Abuse Treat. 1996;13: Abstract 10.Myrick H. Substance abuse and social phobia. Program and abstracts of the American Psychiatric Association 156th Annual Meeting; May 17-22, 2003; San Francisco, California. Abstract S103D. 11.Thevos AK, Roberts JS, Thomas SE, Randall CL. Cognitive behavioral therapy delays relapse in female socially phobic alcoholics. Addict Behav. 2000;25: Abstract 12.Randall CL, Johnson MR, Thevos AK, et al. Paroxetine for social anxiety and alcohol use in dual-diagnosed patients. Depress Anxiety. 2001;14: Abstract

Bipolar disorder and alcoholism

Bipolar disorder and alcoholism Bipolar Disorder and Alcoholism Susan C. Sonne, PharmD, and Kathleen T. Brady, M.D., Ph.D. Bipolar disorder and alcoholism commonly co-occur. Multiple explanations for the relationship between these conditions

More information

ADHD and Substance Use Disorders: An Intoxicating Combination

ADHD and Substance Use Disorders: An Intoxicating Combination ADHD and Substance Use Disorders: An Intoxicating Combination Timothy E. Wilens, MD Chief, Division of Child & Adolescent Psychiatry Director, Center for Addiction Medicine Massachusetts General Hospital

More information

Substance use and perceived symptom improvement among patients with bipolar disorder and substance dependence

Substance use and perceived symptom improvement among patients with bipolar disorder and substance dependence Journal of Affective Disorders 79 (2004) 279 283 Brief report Substance use and perceived symptom improvement among patients with bipolar disorder and substance dependence Roger D. Weiss a,b, *, Monika

More information

Anxiety Disorders. Fear & Anxiety. Anxiety Disorder? 26/5/2014. J. H. Atkinson, M.D. Fear. Anxiety. An anxiety disorder is present when

Anxiety Disorders. Fear & Anxiety. Anxiety Disorder? 26/5/2014. J. H. Atkinson, M.D. Fear. Anxiety. An anxiety disorder is present when Anxiety s J. H. Atkinson, M.D. HIV Neurobehavioral Research Center University of California, San Diego Department of Psychiatry & Veterans Affairs Healthcare System, San Diego Materials courtesy of Dr.

More information

Terminology. ECA Study. Studies on Co morbidity Most widely cited studies: Dual dx MICA CAMI Co Morbid Disorders Co Occurring Disorders

Terminology. ECA Study. Studies on Co morbidity Most widely cited studies: Dual dx MICA CAMI Co Morbid Disorders Co Occurring Disorders Psychiatric Co Morbidities Jeffrey Selzer, MD, FASAM Associate Professor of Psychiatry Hofstra North Shore LIJ School of Medicine Albert Einstein College of Medicine Medical Director, NYS Committee for

More information

A Clinical Translation of the Research Article Titled Antisocial Behavioral Syndromes and. Additional Psychiatric Comorbidity in Posttraumatic Stress

A Clinical Translation of the Research Article Titled Antisocial Behavioral Syndromes and. Additional Psychiatric Comorbidity in Posttraumatic Stress 1 A Clinical Translation of the Research Article Titled Antisocial Behavioral Syndromes and Additional Psychiatric Comorbidity in Posttraumatic Stress Disorder among US Adults: Results from Wave 2 of the

More information

Brief Psychiatric History and Mental Status Examination

Brief Psychiatric History and Mental Status Examination 2 Brief Psychiatric History and Mental Status Examination John R. Vanin A comprehensive medical evaluation includes a thorough history, physical examination, and appropriate laboratory, imaging and other

More information

The Use of Collateral Reports for Patients with Bipolar and Substance Use Disorders

The Use of Collateral Reports for Patients with Bipolar and Substance Use Disorders AM. J. DRUG ALCOHOL ABUSE, 26(3), pp. 369 378 (2000) The Use of Collateral Reports for Patients with Bipolar and Substance Use Disorders Roger D. Weiss, M.D.* Shelly F. Greenfield, M.D., M.P.H. Margaret

More information

An Overview of Anxiety Disorders. Made available to ACT courtesy of Freedom From Fear. Jack D. Maser, Ph.D. National Institute of Mental Health

An Overview of Anxiety Disorders. Made available to ACT courtesy of Freedom From Fear. Jack D. Maser, Ph.D. National Institute of Mental Health An Overview of Anxiety Disorders Made available to ACT courtesy of Freedom From Fear Jack D. Maser, Ph.D. National Institute of Mental Health Fear and anxiety are a normal part of life, even adaptive in

More information

Managing ADHD in the Primary Care Setting

Managing ADHD in the Primary Care Setting Managing ADHD in the Primary Care Setting Andrea E. Spencer, MD Assistant Professor of Psychiatry Boston University School of Medicine Boston Medical Center March 17, 2017 Disclosures Neither I nor my

More information

ALCOHOL DEPENDENCE SYNDROME AND OTHER PSYCHIATRIC ILLNESSESS

ALCOHOL DEPENDENCE SYNDROME AND OTHER PSYCHIATRIC ILLNESSESS Research article ALCOHOL DEPENDENCE SYNDROME AND OTHER PSYCHIATRIC ILLNESSESS Dr. Amitabh Saha Dept of Psychiatry, Command Hospital Pune -411040 India E-mail: sahaing@gmail.com Abstract Alcohol is the

More information

Concurrent Disorders

Concurrent Disorders Concurrent Disorders Dr. Christy Sutherland MD CCFP dipabam Medical Director, PHS Community Services Methadone/Buprenorphine 101 Workshop April 1, 2017 Overview Introduction Epidemiology Treatment Principles

More information

Intro to Concurrent Disorders

Intro to Concurrent Disorders CSAM-SCAM Fundamentals Intro to Concurrent Disorders Presentation provided by Jennifer Brasch, MD, FRCPC Psychiatrist, Concurrent Disorders Program, St. Joseph s Healthcare There are all kinds of addicts,

More information

The Intersection of Post-Traumatic Stress and Substance Use Disorders. Implications for an emerging integrated treatment approach

The Intersection of Post-Traumatic Stress and Substance Use Disorders. Implications for an emerging integrated treatment approach The Intersection of Post-Traumatic Stress and Substance Use Disorders Implications for an emerging integrated treatment approach Christal L. Badour, PhD Assistant Professor Department of Psychology Overview

More information

Therapeutic approaches to the treatment of post traumatic stress disorder and substance use in adults and adolescents

Therapeutic approaches to the treatment of post traumatic stress disorder and substance use in adults and adolescents Therapeutic approaches to the treatment of post traumatic stress disorder and substance use in adults and adolescents Natalie Peach 1, Katherine Mills 1, Emma Barrett 1, Vanessa Cobham 2, Joanne Ross 1,

More information

Co-Occurring Mental Health and Substance Use Disorders. DATE: 4/17/18 PRESENTED BY: John Mahan, MD

Co-Occurring Mental Health and Substance Use Disorders. DATE: 4/17/18 PRESENTED BY: John Mahan, MD Co-Occurring Mental Health and Substance Use Disorders DATE: 4/17/18 PRESENTED BY: John Mahan, MD Disclosure Information Speaker: John Mahan, MD has nothing to disclose Planning Committee: The members

More information

Adolescent Substance Abuse and Psychiatric Comorbidities. Deborah Deas, M.D., M.P.H.

Adolescent Substance Abuse and Psychiatric Comorbidities. Deborah Deas, M.D., M.P.H. Deborah Deas Adolescent Substance Abuse and Psychiatric Comorbidities Deborah Deas, M.D., M.P.H. Substance use disorders have a serious impact on adolescents because these disorders have high prevalence

More information

Comorbidity of Substance Use Disorders and Psychiatric Conditions-2

Comorbidity of Substance Use Disorders and Psychiatric Conditions-2 Comorbidity of Substance Use Disorders and Psychiatric Conditions-2 J. H. Atkinson, M.D. Professor of Psychiatry HIV Neurobehavioral Research Programs University of California, San Diego KETHEA, Athens,

More information

ADOLESCENT SUBSTANCE ABUSE & THE FAMILY

ADOLESCENT SUBSTANCE ABUSE & THE FAMILY ADOLESCENT SUBSTANCE ABUSE & THE FAMILY KARA S. BAGOT, M.D. UNIVERSITY OF CALIFORNIA, SAN DIEGO OVERVIEW HBO ADDICTION -VIDEO EPIDEMIOLOGY OF ADOLESCENT SUBSTANCE USE ADOLESCENT NEURODEVELOPMENT COMORBID

More information

Obsessive-Compulsive Disorder Clinical Practice Guideline Summary for Primary Care

Obsessive-Compulsive Disorder Clinical Practice Guideline Summary for Primary Care Obsessive-Compulsive Disorder Clinical Practice Guideline Summary for Primary Care CLINICAL ASSESSMENT AND DIAGNOSIS (ADULTS) Obsessive-Compulsive Disorder (OCD) is categorized by recurrent obsessions,

More information

Relationship Between Stress and Substance Use Disorders: Neurobiologic Interface

Relationship Between Stress and Substance Use Disorders: Neurobiologic Interface Relationship Between Stress and Substance Use Disorders: Neurobiologic Interface Kathleen Brady, M.D., Ph.D. Professor of Psychiatry Associate Dean of Clinical and Translational Research Medical University

More information

5 COMMON QUESTIONS WHEN TREATING DEPRESSION

5 COMMON QUESTIONS WHEN TREATING DEPRESSION 5 COMMON QUESTIONS WHEN TREATING DEPRESSION Do Antidepressants Increase the Possibility of Suicide? Will I Accidentally Induce Mania if I Prescribe an SSRI? Are Depression Medications Safe and Effective

More information

Mood Disorders and Addictions: A shared biology?

Mood Disorders and Addictions: A shared biology? Mood Disorders and Addictions: A shared biology? Dr. Paul Stokes Clinical Senior Lecturer, Centre for Affective Disorders, Department of Psychological Medicine Disclosures No relevant disclosures: No paid

More information

Psychosis, Mood, and Personality: A Clinical Perspective

Psychosis, Mood, and Personality: A Clinical Perspective Psychosis, Mood, and Personality: A Clinical Perspective John R. Chamberlain, M.D. Assistant Director, Psychiatry and the Law Program Assistant Clinical Professor University of California San Francisco

More information

UNDERSTANDING DEPRESSION Young Adult: Get the Facts

UNDERSTANDING DEPRESSION Young Adult: Get the Facts UNDERSTANDING DEPRESSION Young Adult: Get the Facts What does it mean when a heath care professional says depression? Hearing a health care professional say you have depression can be confusing. The good

More information

Comorbidity of Depression and Other Diseases

Comorbidity of Depression and Other Diseases Comorbidity of Depression and Other Diseases JMAJ 44(5): 225 229, 2001 Masaru MIMURA Associate Professor, Department of Psychiatry, Showa University, School of Medicine Abstract: This paper outlines the

More information

CO-OCCURRING SUBSTANCE USE AND PSYCHIATRIC DISORDERS INTEGRATING COMBINED THERAPIES (ICT) FOR CO-OCCURRING SUBSTANCE USE AND PSYCHIATRIC DISORDERS

CO-OCCURRING SUBSTANCE USE AND PSYCHIATRIC DISORDERS INTEGRATING COMBINED THERAPIES (ICT) FOR CO-OCCURRING SUBSTANCE USE AND PSYCHIATRIC DISORDERS INTEGRATING COMBINED THERAPIES (ICT) FOR CO-OCCURRING SUBSTANCE USE AND PSYCHIATRIC DISORDERS 2009 MARRCH CONFERENCE 22 October 2009 CO-OCCURRING SUBSTANCE USE AND PSYCHIATRIC DISORDERS 1. Common in the

More information

The Stress Vulnerability Model of Co-Occurring Disorders

The Stress Vulnerability Model of Co-Occurring Disorders 1 The Stress Vulnerability Model of Co-Occurring Disorders What causes a chronic illness such as mental illness or a substance use disorder? Why do some people develop a particular illness but not others?

More information

Concurrent Disorders. Christian G. Schütz MD PhD MPH FRCPC. Associate Professor UBC Research and Education Medical Manager BCMHA/PHSA

Concurrent Disorders. Christian G. Schütz MD PhD MPH FRCPC. Associate Professor UBC Research and Education Medical Manager BCMHA/PHSA Concurrent Disorders Christian G. Schütz MD PhD MPH FRCPC Associate Professor UBC Research and Education Medical Manager BCMHA/PHSA Overview What Are Concurrent Disorders? How Common Are They? Treatment

More information

Advocating for people with mental health needs and developmental disability GLOSSARY

Advocating for people with mental health needs and developmental disability GLOSSARY Advocating for people with mental health needs and developmental disability GLOSSARY Accrued deficits: The delays or lack of development in emotional, social, academic, or behavioral skills that a child

More information

Treating Depression in Disadvantaged Women: What is the evidence?

Treating Depression in Disadvantaged Women: What is the evidence? Treating Depression in Disadvantaged Women: What is the evidence? Megan Dwight Johnson, MD MPH Associate Professor Medical Director, UWMC Inpatient Psychiatry Department of Psychiatry and Behavioral Sciences

More information

ADHD & Addictions -What We Know

ADHD & Addictions -What We Know ADHD & Addictions -What We Know Dr. David Teplin, Psy.D., C.Psych. 4th CADDAC Annual Conference, Toronto October 14, 2012 1 Introduction Adult ADHD commonly co-exists with several other disorders, including

More information

BroadcastMed Bipolar, Borderline, Both? Diagnostic/Formulation Issues in Mood and Personality Disorders

BroadcastMed Bipolar, Borderline, Both? Diagnostic/Formulation Issues in Mood and Personality Disorders BroadcastMed Bipolar, Borderline, Both? Diagnostic/Formulation Issues in Mood and Personality Disorders BRIAN PALMER: Hi. My name is Brian Palmer. I'm a psychiatrist here at Mayo Clinic. Today, we'd like

More information

Mood Disorders for Care Coordinators

Mood Disorders for Care Coordinators Mood Disorders for Care Coordinators David A Harrison, MD, PhD Assistant Professor, Dept of Psychiatry & Behavioral Sciences University of Washington School of Medicine Introduction 1 of 3 Mood disorders

More information

Mental Illness and Disorders Notes

Mental Illness and Disorders Notes Mental Illness and Disorders Notes Stigma - is a negative and often unfair about mental illness and disorders can cause people with these to not seek help. Deny problem, feel shame and -feel as if they

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Index Note: Page numbers of article titles are in boldface type. A Age as factor in selective mutism, 623 as factor in social phobia, 623 Agoraphobia, 593 600 described, 594 596 DSM-V changes related to,

More information

The shift in nosology from the Diagnostic PROCEEDINGS FROM CHILDHOOD TO ADOLESCENCE: DIAGNOSIS AND COMORBIDITY ISSUES * Thomas J. Spencer, MD ABSTRACT

The shift in nosology from the Diagnostic PROCEEDINGS FROM CHILDHOOD TO ADOLESCENCE: DIAGNOSIS AND COMORBIDITY ISSUES * Thomas J. Spencer, MD ABSTRACT FROM CHILDHOOD TO ADOLESCENCE: DIAGNOSIS AND COMORBIDITY ISSUES * Thomas J. Spencer, MD ABSTRACT Attention-deficit/hyperactivity disorder (ADHD) tends to manifest differently in adolescents than in children,

More information

Childhood ADHD is a risk factor for some Psychiatric Disorders and co-morbidities

Childhood ADHD is a risk factor for some Psychiatric Disorders and co-morbidities Childhood ADHD is a risk factor for some Psychiatric Disorders and co-morbidities By: Dr. Ehsane M. Gad M.B.B.Ch CABMSPsych. D.P.P Post-Fellow Aus. Consultant Child Psychiatry Childhood ADHD and emergence

More information

Condensed Clinical Practice Guideline Treatment Of Patients With Schizophrenia

Condensed Clinical Practice Guideline Treatment Of Patients With Schizophrenia Condensed Clinical Practice Guideline Treatment Of Patients With Schizophrenia I. Key Points a. Schizophrenia is a chronic illness affecting all aspects of person s life i. Treatment Planning Goals 1.

More information

SUBSTANCE USE DISORDER IN ADOLESCENT POPULATION

SUBSTANCE USE DISORDER IN ADOLESCENT POPULATION Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences SUBSTANCE USE DISORDER IN ADOLESCENT POPULATION ANNABELLE SIMPSON, MD UNIVERSITY OF WASHINGTON GENERAL DISCLOSURES

More information

Challenges in identifying and treating bipolar depression: a guide

Challenges in identifying and treating bipolar depression: a guide Challenges in identifying and treating bipolar depression: a guide Dr. Paul Stokes Clinical Senior Lecturer, Centre for Affective Disorders, Department of Psychological Medicine Overview Challenges in

More information

Post-Traumatic Stress Disorder

Post-Traumatic Stress Disorder Post-Traumatic Stress Disorder "I was raped when I was 25 years old. For a long time, I spoke about the rape as though it was something that happened to someone else. I was very aware that it had happened

More information

INDEX. P. 2 Provisional List of Potentially Harmful Therapies (Adapted from Lilienfeld, 2007)

INDEX. P. 2 Provisional List of Potentially Harmful Therapies (Adapted from Lilienfeld, 2007) Comprehensive List of Currently-Identified Potentially Harmful (PHTs) and Empirically Supported Psychological Treatments (ESTs) for Adults, Adolescents, and Children INDEX P. 2 Provisional List of Potentially

More information

W. De La Haye, M.D., M.P.H., D.M. Department of Community Health & Psychiatry, The University of the West Indies, Mona Campus, JAMAICA

W. De La Haye, M.D., M.P.H., D.M. Department of Community Health & Psychiatry, The University of the West Indies, Mona Campus, JAMAICA W. De La Haye, M.D., M.P.H., D.M. Department of Community Health & Psychiatry, The University of the West Indies, Mona Campus, JAMAICA Less severe mental disorder/more severe substance abuse disorder

More information

Mental Health Problems in Individuals with Prenatal Alcohol Exposure and Fetal Alcohol Spectrum Disorder

Mental Health Problems in Individuals with Prenatal Alcohol Exposure and Fetal Alcohol Spectrum Disorder Mental Health Problems in Individuals with Prenatal Alcohol Exposure and Fetal Alcohol Spectrum Disorder Presenter: Date: Jacqueline Pei, R. Psych., PhD Carmen Rasmussen, PhD May 5, 2009 The FASD Learning

More information

UMASS TOBACCO TREATMENT SPECIALIST CORE TRAINING

UMASS TOBACCO TREATMENT SPECIALIST CORE TRAINING UMASS TOBACCO TREATMENT SPECIALIST CORE TRAINING Course Description Goals and Learning Objectives 55 Lake Ave North, Worcester, MA 01655 www.umassmed.edu/tobacco 1 Table of Contents Determinants of Nicotine

More information

9/12/2012 ALCOHOL AND DRUG USE, ASSOCIATED DISORDERS AND THEIR PSYCHIATRIC COMORBIDITIES IN U.S. ADULTS OBJECTIVES

9/12/2012 ALCOHOL AND DRUG USE, ASSOCIATED DISORDERS AND THEIR PSYCHIATRIC COMORBIDITIES IN U.S. ADULTS OBJECTIVES ALCOHOL AND DRUG USE, ASSOCIATED DISORDERS AND THEIR PSYCHIATRIC COMORBIDITIES IN U.S. ADULTS Risë B. Goldstein, Ph.D., M.P.H., Staff Scientist Laboratory of Epidemiology and Biometry Division of Intramural

More information

Adherence in A Schizophrenia:

Adherence in A Schizophrenia: Understanding and Diagnosing Bipolar Disorder Treatment Promoting for Bipolar Treatment Disorder Adherence in A Schizophrenia: Resource for Providers Engagement Strategies for Health Care Providers, Case

More information

9/29/2011 TRENDS IN MENTAL DISORDERS. Trends in Child & Adolescent Mental Health: What to look for and what to do about it. Autism Spectrum Disorders

9/29/2011 TRENDS IN MENTAL DISORDERS. Trends in Child & Adolescent Mental Health: What to look for and what to do about it. Autism Spectrum Disorders Trends in Child & Adolescent Mental Health: What to look for and what to do about it. Jason J. Washburn, Ph.D., ABPP Director, Center for Evidence-Based Practice TRENDS IN MENTAL DISORDERS Autism Spectrum

More information

Timothy E. Wilens, M.D. ADHD & Substance Use Disorders

Timothy E. Wilens, M.D. ADHD & Substance Use Disorders Timothy E. Wilens, M.D. ADHD & Substance Use Disorders Chief, Division of Child & Adolescent Psychiatry; (Co) Director, Center for Addiction Medicine Massachusetts General Hospital Harvard Medical School

More information

CLINICAL ASPECTS Do Co-morbid Anxiety Disorders Predict Drinking Outcomes in Women with Alcohol Use Disorders?

CLINICAL ASPECTS Do Co-morbid Anxiety Disorders Predict Drinking Outcomes in Women with Alcohol Use Disorders? Alcohol and Alcoholism Vol. 47, No. 2, pp. 143 148, 2012 Advance Access Publication 2 January 2012 doi: 10.1093/alcalc/agr155 CLINICAL ASPECTS Do Co-morbid Anxiety Disorders Predict Drinking Outcomes in

More information

Trends in Child & Adolescent Mental Health: What to look for and what to do about it.

Trends in Child & Adolescent Mental Health: What to look for and what to do about it. Trends in Child & Adolescent Mental Health: What to look for and what to do about it. Jason J. Washburn, Ph.D., ABPP Director, Center for Evidence-Based Practice TRENDS IN MENTAL DISORDERS 1 Autism Spectrum

More information

SECTION 1. Children and Adolescents with Depressive Disorder: Summary of Findings. from the Literature and Clinical Consultation in Ontario

SECTION 1. Children and Adolescents with Depressive Disorder: Summary of Findings. from the Literature and Clinical Consultation in Ontario SECTION 1 Children and Adolescents with Depressive Disorder: Summary of Findings from the Literature and Clinical Consultation in Ontario Children's Mental Health Ontario Children and Adolescents with

More information

UNDERSTANDING BIPOLAR DISORDER Caregiver: Get the Facts

UNDERSTANDING BIPOLAR DISORDER Caregiver: Get the Facts UNDERSTANDING BIPOLAR DISORDER Caregiver: Get the Facts What does it mean when a health care professional says bipolar disorder? Hearing a health care professional say your youth or young adult has bipolar

More information

Topic 2: The Stress-Vulnerability Model of Co-occurring Disorders

Topic 2: The Stress-Vulnerability Model of Co-occurring Disorders The Stress-Vulnerability Model of Co-occurring Disorders What causes psychiatric disorders? Why do some people develop a psychiatric disorder but not others? What affects the course of the disorder? s

More information

UNDERSTANDING BIPOLAR DISORDER Young Adult: Get the Facts

UNDERSTANDING BIPOLAR DISORDER Young Adult: Get the Facts UNDERSTANDING BIPOLAR DISORDER Young Adult: Get the Facts What does it mean when a health care professional says bipolar disorder? At first, it was quite scary Hearing a health care professional say you

More information

Typical or Troubled? Teen Mental Health

Typical or Troubled? Teen Mental Health Typical or Troubled? Teen Mental Health Adolescence is a difficult time for many teens, but how does one know the difference between typical teen issues and behavior that might signal a more serious problem?

More information

To Associate Post Traumatic Stress and Sociodemographic Variables among Children with Congenital Heart Disease

To Associate Post Traumatic Stress and Sociodemographic Variables among Children with Congenital Heart Disease International Academic Institute for Science and Technology International Academic Journal of Humanities Vol. 4, No. 1, 2017, pp. 31-36. ISSN 2454-2245 International Academic Journal of Humanities www.iaiest.com

More information

Wonder Girls to Wonder Women: Lessons Learned from a Longitudinal Study of Girls with ADHD

Wonder Girls to Wonder Women: Lessons Learned from a Longitudinal Study of Girls with ADHD Wonder Girls to Wonder Women: Lessons Learned from a Longitudinal Study of Girls with ADHD Christine Zalecki, Ph.D. Associate Clinical Professor, UC San Francisco Director, Berkeley Girls with ADHD Longitudinal

More information

Co-Occurring Mental Health and Substance Use Disorders. DATE: 11/14/2017 PRESENTED BY: John Mahan, MD

Co-Occurring Mental Health and Substance Use Disorders. DATE: 11/14/2017 PRESENTED BY: John Mahan, MD Co-Occurring Mental Health and Substance Use Disorders DATE: 11/14/2017 PRESENTED BY: John Mahan, MD Disclosure Information Speaker: John Mahan, MD has nothing to disclose Learning Objectives Understand

More information

Trauma and Addiction

Trauma and Addiction Trauma and Addiction Martha T. Kane, PhD Clinical Director, Center for Addiction Medicine Clinical Director, Ambulatory Services Psychiatry Department Massachusetts General Hospital Disclosures Neither

More information

POSTER PRESENTATIONS

POSTER PRESENTATIONS POSTER PRESENTATIONS The following are summaries of posters presented at the American Psychiatric Association Annual Meeting held in Philadelphia, Pennsylvania, May 18-23, 2002 DOES STIMULANT THERAPY FOR

More information

TITLE: Practice parameters for the assessment and treatment of children and adolescents with posttraumatic stress disorder.

TITLE: Practice parameters for the assessment and treatment of children and adolescents with posttraumatic stress disorder. Brief Summary TITLE: Practice parameters for the assessment and treatment of children and adolescents with posttraumatic stress disorder. SOURCE(S): Practice parameters for the assessment and treatment

More information

GOALS FOR THE PSCYHIATRY CLERKSHIP

GOALS FOR THE PSCYHIATRY CLERKSHIP GOALS FOR THE PSCYHIATRY CLERKSHIP GOALS - The aim of the core psychiatry clerkship is to expose students to patients with mental illness and to prepare them to provide psychiatric care at a basic level.

More information

Brief Notes on the Mental Health of Children and Adolescents

Brief Notes on the Mental Health of Children and Adolescents Brief Notes on the Mental Health of Children and Adolescents The future of our country depends on the mental health and strength of our young people. However, many children have mental health problems

More information

Mental Health Issues and Treatment

Mental Health Issues and Treatment Mental Health Issues and Treatment Mental health in older age Depression Causes of depression Effects of depression Suicide Newsom, Winter 2017, Psy 462/562 Psychology of Adult Development and Aging 1

More information

Major Depressive Disorder (MDD) in Children under Age 6

Major Depressive Disorder (MDD) in Children under Age 6 in Children under Age 6 Level 0 Comprehensive assessment. Refer to Principles of Practice on page 6. Level 1 Psychotherapeutic intervention (e.g., dyadic therapy) for 6 to 9 months; assessment of parent/guardian

More information

Pediatric Primary Care Mental Health Specialist Certification Exam. Detailed Content Outline

Pediatric Primary Care Mental Health Specialist Certification Exam. Detailed Content Outline Pediatric Primary Care Mental Health Specialist Certification Exam Detailed Content Outline Description of the Specialty The Pediatric Primary Care Mental Health Specialist (PMHS) builds upon the Advanced

More information

The burden of mental disorders, such as depression and anxiety, fall disproportionately on women of childbearing and childrearing age.

The burden of mental disorders, such as depression and anxiety, fall disproportionately on women of childbearing and childrearing age. The burden of mental disorders, such as depression and anxiety, fall disproportionately on women of childbearing and childrearing age. Psychiatric Clinics of North America, 2007 Rates of severe mental

More information

Reducing the HIV Burden: The PATH for Triples Intervention (PFT)

Reducing the HIV Burden: The PATH for Triples Intervention (PFT) Reducing the HIV Burden: The PATH for Triples Intervention (PFT) Tania Calle SUMR Scholar 2018 Williams College Mentors: Donna Coviello, PhD, and Michael Blank, PhD Penn Center for AIDS Research Significance

More information

Rates of Co-Occurring Disorders Among Youth. Working with Adolescents with Substance Use Disorders

Rates of Co-Occurring Disorders Among Youth. Working with Adolescents with Substance Use Disorders 1 Working with Adolescents with Substance Use Disorders Michael S. Levy, Ph.D. CAB Health & Recovery Services, Inc. Health and Education Services 8% of 12-17 year old youth have substance abuse or dependence

More information

Major Depressive Disorder (MDD) in Children under Age 6

Major Depressive Disorder (MDD) in Children under Age 6 in Children under Age 6 Level 0 Comprehensive assessment. Refer to Principles of Practice on page 5. Level 1 Psychotherapeutic intervention (e.g., dyadic therapy) for 6 to 9 months; assessment of parent/guardian

More information

MOOD (AFFECTIVE) DISORDERS and ANXIETY DISORDERS

MOOD (AFFECTIVE) DISORDERS and ANXIETY DISORDERS MOOD (AFFECTIVE) DISORDERS and ANXIETY DISORDERS Shelley Klipp AS91 Spring 2010 TIP 42 Pages 226-231 and 369-379 DSM IV-TR APA 2000 Co-Occurring Substance Abuse and Mental Disorders by John Smith Types

More information

PSYCHIATRIC CO-MORBIDITY STEVE SUGDEN MD MPH

PSYCHIATRIC CO-MORBIDITY STEVE SUGDEN MD MPH PSYCHIATRIC CO-MORBIDITY STEVE SUGDEN MD MPH OVERVIEW: PSYCHIATRIC DISORDERS Mood Disorders Anxiety Disorders Psychotic Disorders Personality Disorders PTSD Eating Disorders EXAMPLE What is the diagnosis?

More information

We also Know INTEGRATED GROUP COGNITIVE BEHAVIORAL THERAPY FOR PATIENTS WITH CONCURRENT DEPRESSIVE AND SUBSTANCE USE DISORDERS

We also Know INTEGRATED GROUP COGNITIVE BEHAVIORAL THERAPY FOR PATIENTS WITH CONCURRENT DEPRESSIVE AND SUBSTANCE USE DISORDERS INTEGRATED GROUP COGNITIVE BEHAVIORAL THERAPY FOR PATIENTS WITH CONCURRENT DEPRESSIVE AND SUBSTANCE USE DISORDERS May 13, 2010 Kasia Galperyn, Ph.D., R. Psych. Kelly Rose, B.A. David Crockford, MD, FRCPC

More information

4/29/2016. Psychosis A final common pathway. Early Intervention in Psychotic Disorders: Necessary, Effective, and Overdue

4/29/2016. Psychosis A final common pathway. Early Intervention in Psychotic Disorders: Necessary, Effective, and Overdue Early Intervention in Psychotic Disorders: Necessary, Effective, and Overdue Disclosures Financial relationships with commercial interests Douglas R. Robbins, M.D. Maine Medical Center Tufts University

More information

Department of Psychiatry & Behavioral Sciences. University of Texas Medical Branch

Department of Psychiatry & Behavioral Sciences. University of Texas Medical Branch Depression in Childhood: Advances and Controversies in Treatment Karen Dineen Wagner, MD, PhD Marie B. Gale Centennial Professor & Vice Chair Department of Psychiatry & Behavioral Sciences Director, Division

More information

Post-Traumatic Stress Disorder (PTSD) Among People Living with HIV

Post-Traumatic Stress Disorder (PTSD) Among People Living with HIV Post-Traumatic Stress Disorder (PTSD) Among People Living with HIV Milton L. Wainberg, M.D. Associate Clinical Professor of Psychiatry College of Physicians and Surgeons Columbia University mlw35@columbia.edu

More information

5/2/2017. By Pamela Pepper PMH, CNS, BC. DSM-5 Growth and Development

5/2/2017. By Pamela Pepper PMH, CNS, BC. DSM-5 Growth and Development By Pamela Pepper PMH, CNS, BC DSM-5 Growth and Development The idea that diagnosis is based on subjective criteria and that those criteria should fall neatly into a set of categories is not sustainable,

More information

the Worry Over Anxiety Disorders in All the Wrong Places How do you detect anxiety disorders? In this article: By Sagar V.

the Worry Over Anxiety Disorders in All the Wrong Places How do you detect anxiety disorders? In this article: By Sagar V. Focus on the University of Toronto Ending Title in All the Wrong Places the Worry Over Anxiety Disorders By Sagar V. Parikh, MD, FRCPC In this article: 1. How do you detect anxiety disorders? 2. What is

More information

Identifying and Treating Anxiety Disorders

Identifying and Treating Anxiety Disorders June 2015 NEWS Identifying and Treating Anxiety Disorders From being afraid of the dark to getting nervous before major exams, some anxiety is a normal part of childhood and adolescence. But when worries

More information

Trauma Care in Children and Youth. Cecilia Margret MD, PhD, MPH March 24, 2018

Trauma Care in Children and Youth. Cecilia Margret MD, PhD, MPH March 24, 2018 Trauma Care in Children and Youth Cecilia Margret MD, PhD, MPH March 24, 2018 Case Bella is a 16 yr old girl who comes to PCP office with school avoidance. She has been caught twice in school, hiding in

More information

BEHAVIORAL HEALTH SERVICES Treatment Groups

BEHAVIORAL HEALTH SERVICES Treatment Groups BEHAVIORAL HEALTH SERVICES Treatment Groups MOTIVATIONAL ENHANCEMENT GROUP This eight week group is design to assist individuals in resolving the ambivalence that is typical and predictable by anyone faced

More information

Alberta Alcohol and Drug Abuse Commission. POSITION ON ADDICTION AND MENTAL HEALTH February 2007

Alberta Alcohol and Drug Abuse Commission. POSITION ON ADDICTION AND MENTAL HEALTH February 2007 Alberta Alcohol and Drug Abuse Commission POSITION ON ADDICTION AND MENTAL HEALTH POSITION The Alberta Alcohol and Drug Abuse Commission (AADAC) recognizes that among clients with addiction problems, there

More information

Post-traumatic stress disorder A brief overview

Post-traumatic stress disorder A brief overview THEME: Trauma and loss Post-traumatic stress disorder A brief overview Simon Howard, Malcolm Hopwood BACKGROUND Post-traumatic stress disorder (PTSD) is an anxiety disorder which occurs following exposure

More information

REVIEW ARTICLE MANAGEMENT OF PATIENTS WITH MOOD DISORDERS AND COMORBID SUDS

REVIEW ARTICLE MANAGEMENT OF PATIENTS WITH MOOD DISORDERS AND COMORBID SUDS MANAGEMENT OF PATIENTS WITH MOOD DISORDERS AND COMORBID SUDS ANNALS OF CLINICAL PSYCHIATRY 2012;24(1):38-55 REVIEW ARTICLE The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations

More information

Kari A. Stephens, PhD & Wayne Bentham, MD Psychiatry & Behavioral Sciences University of Washington. Approach for doing differential diagnosis of PTSD

Kari A. Stephens, PhD & Wayne Bentham, MD Psychiatry & Behavioral Sciences University of Washington. Approach for doing differential diagnosis of PTSD IN PRIMARY CARE June 17, 2010 Kari A. Stephens, PhD & Wayne Bentham, MD Psychiatry & Behavioral Sciences University of Washington Defining and assessing Approach for doing differential diagnosis of Best

More information

2017 INTERNATIONAL MENTAL HEALTH RESEARCH SYMPOSIUM Friday, October 27, :00am 4:30pm

2017 INTERNATIONAL MENTAL HEALTH RESEARCH SYMPOSIUM Friday, October 27, :00am 4:30pm 2017 INTERNATIONAL MENTAL HEALTH RESEARCH SYMPOSIUM Friday, October 27, 2017 9:00am 4:30pm Kaufman Music Center 129 West 67 th Street (b/w Broadway & Amsterdam) New York, NY 10023 Are There Breakthrough

More information

Effective Treatment of Depression in Older African Americans: Overcoming Barriers

Effective Treatment of Depression in Older African Americans: Overcoming Barriers Effective Treatment of Depression in Older African Americans: Overcoming Barriers R U T H S H I M, M D, M P H A S S I S T A N T P R O F E S S O R, D E P A R T M E N T O F P S Y C H I A T R Y A N D B E

More information

Posttraumatic Stress Disorder

Posttraumatic Stress Disorder Posttraumatic Stress Disorder Amanda Smith, Ph.D., & Gretchen H. Wilber, Psy.D. Staff Psychologists, PTSD Program Albany Stratton VAMC Roadmap/Outline for Today s Talk PTSD incidence, symptoms, etiology

More information

Anxiety Disorders: First aid and when to refer on

Anxiety Disorders: First aid and when to refer on Anxiety Disorders: First aid and when to refer on Presenter: Dr Roger Singh, Consultant Psychiatrist, ABT service, Hillingdon Educational resources from NICE, 2011 NICE clinical guideline 113 What is anxiety?

More information

Dr. Catherine Mancini and Laura Mishko

Dr. Catherine Mancini and Laura Mishko Dr. Catherine Mancini and Laura Mishko Interviewing Depression, with case study Screening When it needs treatment Anxiety, with case study Screening When it needs treatment Observation Asking questions

More information

11/12/2017. How effective are treatments of psychiatric disorders in children and adolescents?

11/12/2017. How effective are treatments of psychiatric disorders in children and adolescents? How effective are treatments of psychiatric disorders in children and adolescents? Benedetto Vitiello, M.D. Pavia, November 22, 2017 1 Disclosure Benedetto Vitiello, M.D. Professor of Child and Adolescent

More information

Rutgers University Course Syllabus Abnormal Psychology 01: 830: 340H7 Summer 3 rd Session 2014

Rutgers University Course Syllabus Abnormal Psychology 01: 830: 340H7 Summer 3 rd Session 2014 Rutgers University Course Syllabus Abnormal Psychology 01: 830: 340H7 Summer 3 rd Session 2014 Date & Time: Monday and Wednesday 6:00PM- 9:40PM Location: LSB rm B115 Livingston Campus Instructor: Stevie

More information

chapter 12 MENTAL HEALTH

chapter 12 MENTAL HEALTH chapter 12 MENTAL HEALTH Mental health problems are a significant cause of ill health and disability. They also are responsible for a substantial portion of the use of health care services. Unfortunately,

More information

Critical Analysis of the Total Transformation Program (TTP) of Legacy Parenting for Helping Behavior Disordered Children and Teens

Critical Analysis of the Total Transformation Program (TTP) of Legacy Parenting for Helping Behavior Disordered Children and Teens Critical Analysis of the Total Transformation Program (TTP) of Legacy Parenting for Helping Behavior Disordered Children and Teens Patricia O. Quinn, MD, FAAP Director, National Center for Girls and Women

More information

Trauma Informed Care for Youth & The VCC Trauma Recovery Program for Youth

Trauma Informed Care for Youth & The VCC Trauma Recovery Program for Youth Trauma Informed Care for Youth & The VCC Trauma Recovery Program for Youth 1 A response that involves intense fear, horror and helplessness; extreme stress that overwhelms the person s capacity to cope

More information

Your Anxious Child: What Parents Need to Know. Caryl Oris, MD

Your Anxious Child: What Parents Need to Know. Caryl Oris, MD Your Anxious Child: What Parents Need to Know Caryl Oris, MD What s Normal? n Normal developmental fears: n Separation Anxiety n Fear of the dark n Separation Anxiety n Fear is a physiological reaction

More information

PTSD: Treatment Opportunities

PTSD: Treatment Opportunities PTSD: Treatment Opportunities Professor Malcolm Hopwood Department of Psychiatry University of Melbourne Professorial Psychiatry Unit, Albert Road Clinic DSM 5: PTSD CRITERION A exposure to: actual or

More information

Assessment and Management of Co-Occurring Psychiatric Illnesses During Office-Based Opioid Treatment

Assessment and Management of Co-Occurring Psychiatric Illnesses During Office-Based Opioid Treatment Assessment and Management of Co-Occurring Psychiatric Illnesses During Office-Based Opioid Treatment Joji Suzuki, MD Assistant Professor of Psychiatry Harvard Medical School Director, Division of Addiction

More information